Search inside SEC filings
Every 10-K, 10-Q, 8-K, proxy and registration statement filed since 2001, searched by what the text actually says. Free, no account, straight through to the document.
At least 10,000 filings contain "Travere"
showing the first 40- Travere Therapeutics, Inc. (TVTX)8-K · 2022-01-06Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)10-K · 2022-02-24Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)10-K · 2025-02-21Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2022-03-11Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2026-05-11Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2022-03-11Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2021-02-12Read the filing on SEC.gov →
- Mirum Pharmaceuticals, Inc. (MIRM)8-K · 2023-09-05Read the filing on SEC.gov →
- LIGAND PHARMACEUTICALS INC8-K · 2021-08-16Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K/A · 2023-09-07Read the filing on SEC.gov →
- Mirum Pharmaceuticals, Inc. (MIRM)8-K/A · 2023-11-02Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2026-05-11Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2023-03-01Read the filing on SEC.gov →
- Mirum Pharmaceuticals, Inc. (MIRM)8-K/A · 2023-11-02Read the filing on SEC.gov →
- Mirum Pharmaceuticals, Inc. (MIRM)8-K/A · 2023-11-02Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2024-11-08Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)DEFA14A · 2025-04-01Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2021-02-12Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)10-K · 2025-02-21Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)10-K · 2024-02-20Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)10-K · 2026-02-19Read the filing on SEC.gov →
- Mirum Pharmaceuticals, Inc. (MIRM)8-K · 2023-07-17Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2024-11-08Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2023-03-01Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)DEFA14A · 2024-03-27Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)10-K · 2022-02-24Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2026-08-04Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2024-02-15Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2025-08-06Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)DEFA14A · 2026-04-06Read the filing on SEC.gov →
- Mirum Pharmaceuticals, Inc. (MIRM)8-K · 2023-07-17Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2025-05-01Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2023-08-03Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2021-05-06Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2024-08-01Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2023-05-04Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2025-10-30Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2024-05-06Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2022-08-04Read the filing on SEC.gov →
- Travere Therapeutics, Inc. (TVTX)8-K · 2023-11-07Read the filing on SEC.gov →
Source: the SEC’s own EDGAR full-text index, which covers filings from 2001 onward. Results are ordered by EDGAR’s relevance. A filing appearing here means the phrase is in the document, nothing more. EDGAR caps its match count at 10,000 and reports anything above that as a lower bound, so the figure above is a floor rather than an exact total.